Jason Eric Evans - 19 Dec 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Reporting relationship: Director
Issuer ticker: TDOC
Reported as of: 19 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Dec 2025, 16:15:36 UTC
Prior SEC filing: 22 Sep 2025
Next SEC filing: 09 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Jason Eric Evans filed Form 4 for Teladoc Health, Inc. (TDOC) on 22 Dec 2025.

Key facts

This page summarizes Jason Eric Evans's Form 4 filing for Teladoc Health, Inc. (TDOC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Dec 2025, 16:15.

Change

Previous filing in this sequence was filed on 22 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001670094 Primary reporting owner

Evans Jason Eric

Relationship: Director
Address: C/O TELADOC HEALTH, INC., 155 E 44TH ST, FLOOR 17, NEW YORK
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date: 22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,016
Change %: +12%
Price
Shares after: 9,145
Date: 19 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,016
Change %: -25%
Price: $0.000000
Shares after: 3,050
Date: 19 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,016
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

On September 20, 2023, the reporting person was granted 12,195 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.